Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [ 177 Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Theranostics · 2024
DOI: 10.7150/thno.93249 ↗Kurz gefasst
Fallbericht in der Zeitschrift Theranostics, 2024. Verfasst von Daria Arbuznikova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lutetium, Heterocyclic Compounds, 1-Ring, Dipeptides. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany and German Cancer Research Center, Heidelberg, Germany.
- Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- German Cancer Consortium (DKTK), partner site Freiburg, a partnership between the German Cancer Research Center and Medical Center - University of Freiburg, Freiburg, Germany.
- Berta-Ottenstein-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Zitieren
APA
Arbuznikova, D., Klotsotyra, A., Uhlmann, L., Domogalla, L. C., Steinacker, N., Mix, M., Niedermann, G., Spohn, S. K. B., Freitag, M. T., Grosu, A. L., Meyer, P. T., Gratzke, C., Eder, M., Zamboglou, C., & Eder, A. C. (2024). Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [ 177 Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside. Theranostics. https://doi.org/10.7150/thno.93249
Vancouver
Arbuznikova D, Klotsotyra A, Uhlmann L, Domogalla LC, Steinacker N, Mix M, et al. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [ 177 Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside. Theranostics. 2024. doi:10.7150/thno.93249
BibTeX
@article{Arbuznikova2024,
author = {Arbuznikova, Daria and Klotsotyra, Aikaterini and Uhlmann, Lisa and Domogalla, Lisa-Charlotte and Steinacker, Nils and Mix, Michael and Niedermann, Gabriele and Spohn, Simon K B and Freitag, Martin T and Grosu, Anca L and Meyer, Philipp T and Gratzke, Christian and Eder, Matthias and Zamboglou, Constantinos and Eder, Ann-Christin},
title = {Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [ 177 Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.93249}
}
EUVIMED